查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2149253

骨盆器官脫垂市場規模、佔有率、成長、全球產業分析、區域趨勢及2026年至2034年預測。

Pelvic Organ Prolapse Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 225 Pages | 商品交期: 2-3個工作天內

價格

骨盆器官脫垂（POP）市場成長要素

全球骨盆器官脫垂（POP）市場規模在2025年達到13.1億美元，預計將從2026年的13.8億美元成長至2034年的22.6億美元，預測期內複合年成長率（CAGR）為6.3%。北美市場在2025年佔主導地位，市佔率達34.35%，這得益於其先進的醫療基礎設施、不斷成長的骨盆底功能障礙診斷病例以及微創治療的廣泛應用。

骨盆器官脫垂是指支撐膀胱、子宮和直腸等骨盆腔器官的肌肉和組織鬆弛無力，導致這些器官偏離正常位置。人口老化、與分娩相關的骨盆底功能障礙、肥胖、更年期、篩檢的改進以及人們對現有治療方法的認知度提高等因素，都推動了這一市場的發展。醫療設備製造商也不斷研發改良的植入、子宮托和微創技術，旨在提高病患的舒適度、減少併發症並縮短恢復時間。

市場關鍵點

全球骨盆器官脫垂（POP）市場預計將從2025年的13.1億美元成長至2026年的13.8億美元，到2034年達到22.6億美元，複合年成長率（CAGR）為6.3%。 2025年，北美繼續保持領先地位，市佔率為34.35%。預計到2026年，手術治療將佔市場佔有率的59.8%，而前骨盆器官脫垂預計將佔48.7%。

市場動態

市場促進因素

老年女性骨盆底疾病負擔加重

老齡化、分娩、閉經、肥胖、子宮切除、慢性咳嗽、體力勞動都會導致骨盆底功能障礙。隨著預期壽命的延長，需要進行檢查和治療的女性人數也不斷增加。篩檢的改進和治療體系的進步也推動了市場的發展。

市場限制因素

植入修復手術的詳細介紹

人們對使用經陰道網片和其他合成支撐材料仍持謹慎態度，這阻礙因素了市場擴張。臨床審查、對長期療效的擔憂、對專業訓練的需求以及對不使用自體組織或植入的治療方法的偏好，都可能減緩新型植入產品的推廣應用。

市場機遇

對微創和器官保留治療的需求日益成長

腹腔鏡和機器人手術日益普及、陰道修復技術不斷進步以及舒適型子宮託的出現，都為女性提供了新的機會。 2025年5月，Mediplus在其POPY子宮托系列中新增了五種尺寸，旨在提供更個人化的非手術支援。

市場趨勢

人們越來越關注以病人為中心的骨盆底護理。

在治療方面，結合骨盆底物理治療、生活方式調整、泌尿功能管理、健康教育和心理支持的方法正變得越來越普遍。數位化骨盆底健康平台和個人化運動計畫也越來越受到關注。

市場挑戰

診斷延遲、社會歧視以及獲得專科醫生服務的機會有限。

羞恥感、文化偏見以及認為骨盆底脫垂是老齡化和分娩的自然結果的觀念，都可能導致診斷延遲。泌尿系統和骨盆底外科醫師數量有限，也限制了患者獲得先進治療的機會。

細分分析

依產品類型

市場細分包括合成網片植入、生物移植物、縫合包、子宮托及其他產品。合成網片植入因其在重組手術中的應用，預計到2025年將佔最大的市場佔有率。子宮托細分市場預計將以6.9%的複合年成長率成長。

治療類型

市場分為手術治療和非手術治療兩大類。預計手術治療將在2025年佔主導地位，並在2026年保持59.8%的市場佔有率。微創骶骨陰道固定術、骶椎夾板固定術和陰道前壁夾板固定術是這一趨勢的主要支撐。非手術治療預計將以5.2%的複合年成長率成長。

骨盆器官脫垂的類型

到2025年，前壁脫垂將佔市場主導地位，預計到2026年將佔48.7%的市場佔有率，這反映了膀胱脫垂的高發生率。後壁脫垂預計將以6.7%的複合年成長率成長。

最終用戶

醫院、專科診所及其他機構構成主要終端使用者群體。憑藉先進的基礎設施和手術能力，醫院在2025年佔市場主導地位，預計2026年市場佔有率將達到58.8%。專科診所預計將以6.9%的複合年成長率成長。

區域展望

北美洲

北美仍然是一個主要地區，預計到 2025 年將達到 4.5 億美元。在先進的骨盆底治療和診斷方法增加的推動下，美國市場預計到 2026 年將達到 4.1 億美元。

歐洲

預計2026年，歐洲市場規模將達到3.7億美元，年複合成長率為5.4%。英國、德國和法國的市場規模預計在2026年分別為6,000萬美元、8,000萬美元和5,000萬美元。

亞太地區

預計到 2026 年，亞太地區的市場規模將達到 3.6 億美元。其中，中國和印度的市場規模預計將分別達到 1.2 億美元和 8,000 萬美元。

拉丁美洲、中東和非洲

預計到 2026 年，拉丁美洲市場規模將達到 8,000 萬美元，而海灣合作理事會市場預計將達到 3,000 萬美元。

目錄

第1章：引言

第2章摘要整理

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第4章：主要考慮因素

  • 骨盆器官脫垂（POP）的技術進步
  • 新產品發布，主要公司
  • 產業重大發展：合併、收購與合作。

第5章：2021-2034年全球骨盆器官脫垂市場分析、洞察與預測

  • 市場分析、洞察與預測：按產品類型分類
    • 合成網狀植入
    • 生物移植
    • 縫合包
    • 子宮托
    • 其他
  • 市場分析、洞察與預測：按治療類型分類
    • 手術治療
      • 骶骨陰道固定術
      • 骶骨子宮切除術
      • 其他
    • 非手術治療
      • 子宮託管理
      • 骨盆底物理治療
      • 其他
  • 市場分析、洞察與預測：按骨盆器官脫垂
    • 陰道前壁脫垂
    • 陰道後壁脫垂
    • 其他
  • 市場分析、洞察與預測：按最終用戶分類
    • 醫院
    • 專科診所
    • 其他
  • 市場分析、洞察與預測：按地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章：北美骨盆器官脫垂市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章：歐洲骨盆器官脫垂市場分析、洞察與預測（2021-2034年）

  • 國家
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪地那維亞
    • 其他歐洲國家

第8章：亞太地區骨盆器官脫垂市場分析、洞察與預測（2021-2034年）

  • 國家
    • 日本
    • 澳洲
    • 中國
    • 印度
    • 東南亞
    • 其他亞太國家

第9章：拉丁美洲骨盆器官脫垂市場分析、洞察與預測（2021-2034年）

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章：中東和非洲骨盆器官脫垂市場分析、洞察與預測（2021-2034年）

  • 國家
    • 南非
    • GCC
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市佔率分析（2024 年）
  • 公司簡介
    • Boston Scientific Corporation
    • Coloplast A/S
    • Johnson & Johnson Services Inc.
    • CooperSurgical Inc.
    • BD
    • Caldera Medical
    • MedGyn Products
    • Integra LifeSciences
    • Symmetry Surgical
    • KARL STORZ
    • B. Braun Melsungen AG
Product Code: FBI114969

Growth Factors of pelvic organ prolapse (POP) Market

The global pelvic organ prolapse (POP) market size was valued at USD 1.31 billion in 2025 and is projected to grow from USD 1.38 billion in 2026 to USD 2.26 billion by 2034, exhibiting a CAGR of 6.3% during the forecast period. North America dominated the market with a 34.35% share in 2025, supported by advanced healthcare infrastructure, increasing diagnosis of pelvic floor disorders, and the availability of minimally invasive treatment options.

Pelvic organ prolapse occurs when the muscles and tissues supporting pelvic organs such as the bladder, uterus, or rectum weaken and allow these organs to shift from their normal position. The market is benefiting from population aging, childbirth-related pelvic floor disorders, obesity, menopause, improved screening, and growing awareness of available treatments. Medical device companies are also developing improved implants, pessaries, and minimally invasive technologies designed to improve patient comfort, reduce complications, and shorten recovery time.

MARKET KEY TAKEAWAYS

The global POP market is expected to increase from USD 1.31 billion in 2025 to USD 1.38 billion in 2026 and reach USD 2.26 billion by 2034, registering a 6.3% CAGR. North America held the leading 34.35% market share in 2025. Surgical treatment is expected to account for 59.8% in 2026, while anterior compartment prolapse is projected to represent 48.7%.

MARKET DYNAMICS

MARKET DRIVERS

Rising Burden of Pelvic Floor Disorders in Aging Women

Increasing age, childbirth, menopause, obesity, hysterectomy, chronic coughing, and physically demanding activities contribute to pelvic floor disorders. Growing life expectancy is increasing the number of women requiring evaluation and treatment. Improved screening and advanced treatment systems are also supporting market expansion.

MARKET RESTRAINTS

Cautious Adoption of Implant-Based Repair Techniques

Cautious use of transvaginal meshes and other synthetic support materials remains a restraint. Clinical scrutiny, concerns regarding long-term outcomes, specialized training requirements, and preference for native-tissue or non-implant approaches can slow adoption of newer implantable products.

MARKET OPPORTUNITIES

Growing Demand for Minimally Invasive and Organ-Preserving Treatments

Increasing preference for laparoscopic and robotic procedures, improved vaginal repair techniques, and comfortable pessaries is creating opportunities. In May 2025, Mediplus expanded its POPY pessary range with five additional sizes to provide more individualized non-surgical support.

MARKET TRENDS

Increasing Focus on Patient-Centered Pelvic Floor Care

Treatment is increasingly combining pelvic floor physiotherapy, lifestyle modification, continence management, education, and psychological support. Digital pelvic health platforms and customized exercise programs are also becoming more prominent.

MARKET CHALLENGES

Underdiagnosis, Stigma, and Limited Specialist Access

Embarrassment, cultural stigma, and the perception that prolapse is a normal consequence of aging or childbirth can delay diagnosis. Limited availability of urogynecologists and specialized pelvic floor surgeons also restricts access to advanced treatment.

SEGMENTATION ANALYSIS

By Product Type

The market is segmented into synthetic mesh implants, biological grafts, suture kits, pessaries, and others. Synthetic mesh implants held the largest share in 2025, supported by their use in reconstructive procedures. The pessaries segment is projected to grow at a 6.9% CAGR.

By Treatment Type

The market is divided into surgical and non-surgical treatment. Surgical treatment dominated in 2025 and is expected to hold 59.8% in 2026, supported by minimally invasive sacrocolpopexy, sacrospinous fixation, and pectopexy. Non-surgical treatment is projected to grow at a 5.2% CAGR.

By Prolapse Type

Anterior compartment prolapse dominated the market in 2025 and is expected to account for 48.7% in 2026, reflecting the high prevalence of cystocele. Posterior compartment prolapse is projected to grow at a 6.7% CAGR.

By End User

Hospitals, specialty clinics, and others constitute the major end-user segments. Hospitals dominated in 2025 and are expected to hold 58.8% in 2026, supported by advanced infrastructure and surgical capabilities. Specialty clinics are projected to grow at a 6.9% CAGR.

REGIONAL OUTLOOK

North America

North America remained the leading region, reaching USD 0.45 billion in 2025. The U.S. market is estimated at USD 0.41 billion in 2026, supported by advanced pelvic floor treatments and increasing diagnosis.

Europe

Europe is projected to reach USD 0.37 billion in 2026, growing at a 5.4% CAGR. The U.K., Germany, and France are estimated at USD 0.06 billion, USD 0.08 billion, and USD 0.05 billion, respectively, in 2026.

Asia Pacific

Asia Pacific is expected to reach USD 0.36 billion in 2026. China and India are estimated at USD 0.12 billion and USD 0.08 billion, respectively.

Latin America and Middle East & Africa

Latin America is expected to reach USD 0.08 billion in 2026, while the GCC market is projected at USD 0.03 billion.

COMPETITIVE LANDSCAPE

Major companies include Boston Scientific Corporation, Coloplast A/S, Johnson & Johnson Services Inc., CooperSurgical Inc., BD, Caldera Medical, MedGyn Products, Integra LifeSciences, Symmetry Surgical, KARL STORZ, and B. Braun Melsungen AG. Companies are focusing on product launches, regulatory approvals, collaborations, commercialization, and expansion into emerging markets.

KEY INDUSTRY DEVELOPMENTS

In June 2025, Escala Medical raised USD 4.5 million for commercialization of its FDA-approved Mendit device. In May 2025, Mediplus expanded its POPY pessary range. In September 2024, ConTIPI Medical partnered with EVERSANA for ProVate commercialization. In February 2022, Medtronic received FDA approval for InterStim X.

REPORT COVERAGE

The report covers the global pelvic organ prolapse market across product type, treatment type, prolapse type, and end user. It includes market dynamics, regional analysis, competitive landscape, product developments, partnerships, approvals, and key strategies adopted by major companies.

CONCLUSION

The global pelvic organ prolapse market is projected to grow from USD 1.31 billion in 2025 to USD 1.38 billion in 2026 and USD 2.26 billion by 2034, at a 6.3% CAGR. Increasing diagnosis of pelvic floor disorders, an aging female population, minimally invasive procedures, patient-centered care, and improved pessary and implant technologies are expected to support market expansion. At the same time, cautious adoption of implant-based treatments, underdiagnosis, stigma, and limited specialist access remain important market considerations.

Segmentation By Product Type, Treatment Type, Prolapse Type, Application, End-user, and Region

By Product Type

  • Synthetic Mesh Implants
  • Biological Grafts
  • Suture Kits
  • Pessaries
  • Others

By Treatment Type

  • Surgical Treatment
    • Sacrocolpopexy
    • Sacrohysteropexy
    • Others
  • Non-surgical Treatment
    • Pessary Management
    • Pelvic Floor Physical Therapy
    • Others

By Prolapse Type

  • Anterior Compartment Prolapse
  • Posterior Compartment Prolapse
  • Others

By End-user

  • Hospitals
  • Specialty Clinics
  • Others

By Region

  • North America (By Product Type, Treatment Type, Prolapse Type, End-user, and Country)
    • U.S. (By Product Type)
    • Canada (By Product Type)
  • Europe (By Product Type, Treatment Type, Prolapse Type, End-user, and Country/Sub-region)
    • Germany (By Product Type)
    • U.K. (By Product Type)
    • France (By Product Type)
    • Spain (By Product Type)
    • Italy (By Product Type)
    • Scandinavia (By Product Type)
    • Rest of Europe (By Product Type)
  • Asia Pacific (By Product Type, Treatment Type, Prolapse Type, End-user, and Country/Sub-region)
    • China (By Product Type)
    • Japan (By Product Type)
    • India (By Product Type)
    • Australia (By Product Type)
    • Southeast Asia (By Product Type)
    • Rest of Asia Pacific (By Product Type)
  • Latin America (By Size, Procedure, End-user, and Country/Sub-region)
    • Brazil (By Product Type)
    • Mexico (By Product Type)
    • Rest of Latin America (By Product Type)
  • Middle East & Africa (By Product Type, Treatment Type, Prolapse Type, End-user, and Country/Sub-region)
    • GCC (By Product Type)
    • South Africa (By Product Type)
    • Rest of the Middle East & Africa (By Product Type)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Technological Advancements in Pelvic Organ Prolapse (POP)
  • 4.2. New Product Launches, Key Players
  • 4.3. Key Industry Developments - Mergers, Acquisitions & Partnerships

5. Global Pelvic Organ Prolapse (POP) Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Synthetic Mesh Implants
    • 5.1.2. Biological Grafts
    • 5.1.3. Suture Kits
    • 5.1.4. Pessaries
    • 5.1.5. Others
  • 5.2. Market Analysis, Insights and Forecast - By Treatment Type
    • 5.2.1. Surgical Treatment
      • 5.2.1.1. Sacrocolpopexy
      • 5.2.1.2. Sacrohysteropexy
      • 5.2.1.3. Others
    • 5.2.2. Non-surgical Treatment
      • 5.2.2.1. Pessary Management
      • 5.2.2.2. Pelvic Floor Physical Therapy
      • 5.2.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By Prolapse Type
    • 5.3.1. Anterior Compartment Prolapse
    • 5.3.2. Posterior Compartment Prolapse
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By End-user
    • 5.4.1. Hospitals
    • 5.4.2. Specialty Clinics
    • 5.4.3. Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East and Africa

6. North America Pelvic Organ Prolapse (POP) Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Synthetic Mesh Implants
    • 6.1.2. Biological Grafts
    • 6.1.3. Suture Kits
    • 6.1.4. Pessaries
    • 6.1.5. Others
  • 6.2. Market Analysis, Insights and Forecast - By Treatment Type
    • 6.2.1. Surgical Treatment
      • 6.2.1.1. Sacrocolpopexy
      • 6.2.1.2. Sacrohysteropexy
      • 6.2.1.3. Others
    • 6.2.2. Non-surgical Treatment
      • 6.2.2.1. Pessary Management
      • 6.2.2.2. Pelvic Floor Physical Therapy
      • 6.2.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By Prolapse Type
    • 6.3.1. Anterior Compartment Prolapse
    • 6.3.2. Posterior Compartment Prolapse
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By End-user
    • 6.4.1. Hospitals
    • 6.4.2. Specialty Clinics
    • 6.4.3. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
      • 6.5.1.1. By Product Type
    • 6.5.2. Canada
      • 6.5.2.1. By Product Type

7. Europe Pelvic Organ Prolapse (POP) Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Synthetic Mesh Implants
    • 7.1.2. Biological Grafts
    • 7.1.3. Suture Kits
    • 7.1.4. Pessaries
    • 7.1.5. Others
  • 7.2. Market Analysis, Insights and Forecast - By Treatment Type
    • 7.2.1. Surgical Treatment
      • 7.2.1.1. Sacrocolpopexy
      • 7.2.1.2. Sacrohysteropexy
      • 7.2.1.3. Others
    • 7.2.2. Non-surgical Treatment
      • 7.2.2.1. Pessary Management
      • 7.2.2.2. Pelvic Floor Physical Therapy
      • 7.2.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By Prolapse Type
    • 7.3.1. Anterior Compartment Prolapse
    • 7.3.2. Posterior Compartment Prolapse
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By End-user
    • 7.4.1. Hospitals
    • 7.4.2. Specialty Clinics
    • 7.4.3. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. U.K.
      • 7.5.1.1. By Product Type
    • 7.5.2. Germany
      • 7.5.2.1. By Product Type
    • 7.5.3. France
      • 7.5.3.1. By Product Type
    • 7.5.4. Spain
      • 7.5.4.1. By Product Type
    • 7.5.5. Italy
      • 7.5.5.1. By Product Type
    • 7.5.6. Scandinavia
      • 7.5.6.1. By Product Type
    • 7.5.7. Rest of Europe
      • 7.5.7.1. By Product Type

8. Asia Pacific Pelvic Organ Prolapse (POP) Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Synthetic Mesh Implants
    • 8.1.2. Biological Grafts
    • 8.1.3. Suture Kits
    • 8.1.4. Pessaries
    • 8.1.5. Others
  • 8.2. Market Analysis, Insights and Forecast - By Treatment Type
    • 8.2.1. Surgical Treatment
      • 8.2.1.1. Sacrocolpopexy
      • 8.2.1.2. Sacrohysteropexy
      • 8.2.1.3. Others
    • 8.2.2. Non-surgical Treatment
      • 8.2.2.1. Pessary Management
      • 8.2.2.2. Pelvic Floor Physical Therapy
      • 8.2.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By Prolapse Type
    • 8.3.1. Anterior Compartment Prolapse
    • 8.3.2. Posterior Compartment Prolapse
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By End-user
    • 8.4.1. Hospitals
    • 8.4.2. Specialty Clinics
    • 8.4.3. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. Japan
      • 8.5.1.1. By Product Type
    • 8.5.2. Australia
      • 8.5.2.1. By Product Type
    • 8.5.3. China
      • 8.5.3.1. By Product Type
    • 8.5.4. India
      • 8.5.4.1. By Product Type
    • 8.5.5. Southeast Asia
      • 8.5.5.1. By Product Type
    • 8.5.6. Rest of Asia Pacific
      • 8.5.6.1. By Product Type

9. Latin America Pelvic Organ Prolapse (POP) Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Synthetic Mesh Implants
    • 9.1.2. Biological Grafts
    • 9.1.3. Suture Kits
    • 9.1.4. Pessaries
    • 9.1.5. Others
  • 9.2. Market Analysis, Insights and Forecast - By Treatment Type
    • 9.2.1. Surgical Treatment
      • 9.2.1.1. Sacrocolpopexy
      • 9.2.1.2. Sacrohysteropexy
      • 9.2.1.3. Others
    • 9.2.2. Non-surgical Treatment
      • 9.2.2.1. Pessary Management
      • 9.2.2.2. Pelvic Floor Physical Therapy
      • 9.2.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By Prolapse Type
    • 9.3.1. Anterior Compartment Prolapse
    • 9.3.2. Posterior Compartment Prolapse
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By End-user
    • 9.4.1. Hospitals
    • 9.4.2. Specialty Clinics
    • 9.4.3. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.5.1. Brazil
      • 9.5.1.1. By Product Type
    • 9.5.2. Mexico
      • 9.5.2.1. By Product Type
    • 9.5.3. Rest of Latin America
      • 9.5.3.1. By Product Type

10. Middle East and Africa Pelvic Organ Prolapse (POP) Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product Type
    • 10.1.1. Synthetic Mesh Implants
    • 10.1.2. Biological Grafts
    • 10.1.3. Suture Kits
    • 10.1.4. Pessaries
    • 10.1.5. Others
  • 10.2. Market Analysis, Insights and Forecast - By Treatment Type
    • 10.2.1. Surgical Treatment
      • 10.2.1.1. Sacrocolpopexy
      • 10.2.1.2. Sacrohysteropexy
      • 10.2.1.3. Others
    • 10.2.2. Non-surgical Treatment
      • 10.2.2.1. Pessary Management
      • 10.2.2.2. Pelvic Floor Physical Therapy
      • 10.2.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By Prolapse Type
    • 10.3.1. Anterior Compartment Prolapse
    • 10.3.2. Posterior Compartment Prolapse
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By End-user
    • 10.4.1. Hospitals
    • 10.4.2. Specialty Clinics
    • 10.4.3. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.5.1. South Africa
      • 10.5.1.1. By Product Type
    • 10.5.2. GCC
      • 10.5.2.1. By Product Type
    • 10.5.3. Rest of Middle East and Africa
      • 10.5.3.1. By Product Type

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2024)
  • 11.2. Company Profiles
    • 11.2.1. Boston Scientific Corporation
    • 11.2.2. Coloplast A/S
    • 11.2.3. Johnson & Johnson Services Inc.
    • 11.2.4. CooperSurgical Inc.
    • 11.2.5. BD
    • 11.2.6. Caldera Medical
    • 11.2.7. MedGyn Products
    • 11.2.8. Integra LifeSciences
    • 11.2.9. Symmetry Surgical
    • 11.2.10. KARL STORZ
    • 11.2.11. B. Braun Melsungen AG

List of Tables

  • Table 1: Global Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 2: Global Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Treatment Type, 2021-2034
  • Table 3: Global Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Surgical Treatment, 2021-2034
  • Table 4: Global Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Non-surgical Treatment, 2021-2034
  • Table 5: Global Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Prolapse Type, 2021-2034
  • Table 6: Global Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 7: Global Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, by Region, 2019-2032
  • Table 8: North America Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 9: North America Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Treatment Type, 2021-2034
  • Table 10: North America Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Surgical Treatment, 2021-2034
  • Table 11: North America Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Non-surgical Treatment, 2021-2034
  • Table 12: North America Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Prolapse Type, 2021-2034
  • Table 13: North America Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 14: North America Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, by Country, 2019-2032
  • Table 15: U.S. Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 16: Canada Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 17: Europe Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 18: Europe Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Treatment Type, 2021-2034
  • Table 19: Europe Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Surgical Treatment, 2021-2034
  • Table 20: Europe Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Non-surgical Treatment, 2021-2034
  • Table 21: Europe Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Prolapse Type, 2021-2034
  • Table 22: Europe Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 23: Europe Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, by Country/Sub-region, 2019-2032
  • Table 24: UK Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 25: Germany Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 26: France Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 27: Spain Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 28: Italy Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 29: Scandinavia Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 30: Rest of Europe Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 31: Asia Pacific Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 32: Asia Pacific Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Treatment Type, 2021-2034
  • Table 33: Asia Pacific Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Surgical Treatment, 2021-2034
  • Table 34: Asia Pacific Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Non-surgical Treatment, 2021-2034
  • Table 35: Asia Pacific Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Prolapse Type, 2021-2034
  • Table 36: Asia Pacific Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 37: Asia Pacific Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, by Country/Sub-region, 2019-2032
  • Table 38: Japan Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 39: Australia Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 40: China Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 41: India Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 42: South East Asia Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 43: Rest of Asia Pacific Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 44: Latin America Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 45: Latin America Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Treatment Type, 2021-2034
  • Table 46: Latin America Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Surgical Treatment, 2021-2034
  • Table 47: Latin America Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Non-surgical Treatment, 2021-2034
  • Table 48: Latin America Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Prolapse Type, 2021-2034
  • Table 49: Latin America Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 50: Latin America Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, by Country/Sub-region, 2019-2032
  • Table 51: Brazil Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 52: Mexico Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 53: Rest of Latin America Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 54: Middle East and Africa Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 55: Middle East and Africa Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Treatment Type, 2021-2034
  • Table 56: Middle East and Africa Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Surgical Treatment, 2021-2034
  • Table 57: Middle East and Africa Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Non-surgical Treatment, 2021-2034
  • Table 58: Middle East and Africa Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Prolapse Type, 2021-2034
  • Table 59: Middle East and Africa Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 60: Middle East and Africa Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, by Country/Sub-region, 2019-2032
  • Table 61: GCC Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 62: South Africa Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 63: Rest of Middle East and Africa Pelvic Organ Prolapse (POP) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034

List of Figures

  • Figure 1: Global Pelvic Organ Prolapse (POP) Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Pelvic Organ Prolapse (POP) Market Value Share (%), By Treatment Type, 2025 & 2034
  • Figure 3: Global Pelvic Organ Prolapse (POP) Market Value Share (%), By Product Type, 2025 & 2034
  • Figure 4: Global Pelvic Organ Prolapse (POP) Market Value Share (%), By Prolapse Type, 2025 & 2034
  • Figure 5: Global Pelvic Organ Prolapse (POP) Market Value Share (%), by End-user, 2025 & 2034
  • Figure 6: Global Pelvic Organ Prolapse (POP) Market Value (USD billion), by Region, 2025 & 2034
  • Figure 7: North America Pelvic Organ Prolapse (POP) Market Value (USD billion), By Product Type, 2025 & 2034
  • Figure 8: North America Pelvic Organ Prolapse (POP) Market Value Share (%), By Product Type, 2025
  • Figure 9: North America Pelvic Organ Prolapse (POP) Market Value (USD billion), By Treatment Type, 2025 & 2034
  • Figure 10: North America Pelvic Organ Prolapse (POP) Market Value Share (%), By Treatment Type, 2025
  • Figure 11: North America Pelvic Organ Prolapse (POP) Market Value (USD billion), By Prolapse Type, 2025 & 2034
  • Figure 12: North America Pelvic Organ Prolapse (POP) Market Value Share (%), By Prolapse Type, 2025
  • Figure 13: North America Pelvic Organ Prolapse (POP) Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 14: North America Pelvic Organ Prolapse (POP) Market Value Share (%), by End-user, 2025
  • Figure 15: North America Pelvic Organ Prolapse (POP) Market Value (USD billion), By Country, 2025 & 2034
  • Figure 16: North America Pelvic Organ Prolapse (POP) Market Value Share (%), By Country, 2025
  • Figure 17: Europe Pelvic Organ Prolapse (POP) Market Value (USD billion), By Product Type, 2025 & 2034
  • Figure 18: Europe Pelvic Organ Prolapse (POP) Market Value Share (%), By Product Type, 2025
  • Figure 19: Europe Pelvic Organ Prolapse (POP) Market Value (USD billion), By Treatment Type, 2025 & 2034
  • Figure 20: Europe Pelvic Organ Prolapse (POP) Market Value Share (%), By Treatment Type, 2025
  • Figure 21: Europe Pelvic Organ Prolapse (POP) Market Value (USD billion), By Prolapse Type, 2025 & 2034
  • Figure 22: Europe Pelvic Organ Prolapse (POP) Market Value Share (%), By Prolapse Type, 2025
  • Figure 23: Europe Pelvic Organ Prolapse (POP) Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 24: Europe Pelvic Organ Prolapse (POP) Market Value Share (%), by End-user, 2025
  • Figure 25: Europe Pelvic Organ Prolapse (POP) Market Value (USD billion), By Country/Sub-region, 2025 & 2034
  • Figure 26: Europe Pelvic Organ Prolapse (POP) Market Value Share (%), By Country/Sub-region, 2025
  • Figure 27: Asia Pacific Pelvic Organ Prolapse (POP) Market Value (USD billion), By Product Type, 2025 & 2034
  • Figure 28: Asia Pacific Pelvic Organ Prolapse (POP) Market Value Share (%), By Product Type, 2025
  • Figure 29: Asia Pacific Pelvic Organ Prolapse (POP) Market Value (USD billion), By Treatment Type, 2025 & 2034
  • Figure 30: Asia Pacific Pelvic Organ Prolapse (POP) Market Value Share (%), By Treatment Type, 2025
  • Figure 31: Asia Pacific Pelvic Organ Prolapse (POP) Market Value (USD billion), By Prolapse Type, 2025 & 2034
  • Figure 32: Asia Pacific Pelvic Organ Prolapse (POP) Market Value Share (%), By Prolapse Type, 2025
  • Figure 33: Asia Pacific Pelvic Organ Prolapse (POP) Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 34: Asia Pacific Pelvic Organ Prolapse (POP) Market Value Share (%), by End-user, 2025
  • Figure 35: Asia Pacific Pelvic Organ Prolapse (POP) Market Value (USD billion), By Country/Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Pelvic Organ Prolapse (POP) Market Value Share (%), By Country/Sub-region, 2025
  • Figure 37: Latin America Pelvic Organ Prolapse (POP) Market Value (USD billion), By Product Type, 2025 & 2034
  • Figure 38: Latin America Pelvic Organ Prolapse (POP) Market Value Share (%), By Product Type, 2025
  • Figure 39: Latin America Pelvic Organ Prolapse (POP) Market Value (USD billion), By Treatment Type, 2025 & 2034
  • Figure 40: Latin America Pelvic Organ Prolapse (POP) Market Value Share (%), By Treatment Type, 2025
  • Figure 41: Latin America Pelvic Organ Prolapse (POP) Market Value (USD billion), By Prolapse Type, 2025 & 2034
  • Figure 42: Latin America Pelvic Organ Prolapse (POP) Market Value Share (%), By Prolapse Type, 2025
  • Figure 43: Latin America Pelvic Organ Prolapse (POP) Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 44: Latin America Pelvic Organ Prolapse (POP) Market Value Share (%), by End-user, 2025
  • Figure 45: Latin America Pelvic Organ Prolapse (POP) Market Value (USD billion), By Country/Sub-region, 2025 & 2034
  • Figure 46: Latin America Pelvic Organ Prolapse (POP) Market Value Share (%), By Country/Sub-region, 2025
  • Figure 47: Middle East and Africa Pelvic Organ Prolapse (POP) Market Value (USD billion), By Product Type, 2025 & 2034
  • Figure 48: Middle East and Africa Pelvic Organ Prolapse (POP) Market Value Share (%), By Product Type, 2025
  • Figure 49: Middle East and Africa Pelvic Organ Prolapse (POP) Market Value (USD billion), By Treatment Type, 2025 & 2034
  • Figure 50: Middle East and Africa Pelvic Organ Prolapse (POP) Market Value Share (%), By Treatment Type, 2025
  • Figure 51: Middle East and Africa Pelvic Organ Prolapse (POP) Market Value (USD billion), By Prolapse Type, 2025 & 2034
  • Figure 52: Middle East and Africa Pelvic Organ Prolapse (POP) Market Value Share (%), By Prolapse Type, 2025
  • Figure 53: Middle East and Africa Pelvic Organ Prolapse (POP) Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 54: Middle East and Africa Pelvic Organ Prolapse (POP) Market Value Share (%), by End-user, 2025
  • Figure 55: Middle East and Africa Pelvic Organ Prolapse (POP) Market Value (USD billion), By Country/Sub-region, 2025 & 2034
  • Figure 56: Middle East and Africa Pelvic Organ Prolapse (POP) Market Value Share (%), By Country/Sub-region, 2025
  • Figure 57: Global Pelvic Organ Prolapse (POP) Market Share (%), By Company, 2025